Paul R. Edick, Chief Executive Officer at Durata Therapeutics, Inc. (DRTX), bought 3,000 shares at $7.09 ($21K) on 2013-05-20, disclosed to the SEC on 2013-05-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| XERS | BUY | 2022-05-13 | $140K | — | Filing → |
| XERS | BUY | 2021-11-16 | $46K | — | Filing → |
| XERS | BUY | 2021-11-12 | $416K | — | Filing → |